Tacrine: a pharmacological review.
Freeman
S E
SE
Materials Research Laboratory (MRL)--DSTO, Melbourne, Australia.
Dawson
R M
RM
D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D000931:Antidotes / Q000494:pharmacology; D002802:Cholinesterases / Q000378:metabolism; D004347:Drug Interactions; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D009020:Morphine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D062025:Organophosphate Poisoning; D011041:Poisoning / Q000188:drug therapy; D011817:Rabbits; D011976:Receptors, Muscarinic / Q000187:drug effects; D013619:Tacrine / Q000494:pharmacology* / Q000627:therapeutic use
D000931:Antidotes; D006213:Hallucinogens; D007473:Ion Channels; D018377:Neurotransmitter Agents; D011976:Receptors, Muscarinic; D013619:Tacrine; D009020:Morphine; D002802:Cholinesterases